Back to search

Article

Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR

2021-03-29

Abstract excerpt

<h4>Background</h4> Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data is sparse. <h4>Methods</h4> In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df2daaff-eaae-5f4d-a053-84eb7c2c45bb
DOI
10.1101/2021.03.27.21253966
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCRDOI 10.1101/2021.03.27.21253966
Select a neighboring publication to make it the new centre.